Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.78 |
| ▸ | APP | P05067 | 2/20 | 0.65 |
| ▸ | SLC16A3 | O15427 | 2/20 | 0.50 |
| ▸ | SLC16A1 | P53985 | 2/20 | 0.50 |
| ▸ | CISD1 | Q9NZ45 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.50 |
| ▸ | EGFR | P00533 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12294129 | 1.00 | MAPT (0.78) | MAPTAPPSLC16A3SLC16A1CISD1 | |
| SCHEMBL12294131 | 0.99 | MAPT (0.80) | MAPTAPPSLC16A3SLC16A1CISD1 | |
| SCHEMBL7006739 | 0.90 | MAPT (0.65) | MAPTAPPSLC16A3SLC16A1CISD1 | |
| SCHEMBL16143964 | 0.90 | MAPT (0.74) | MAPTAPPSLC16A3SLC16A1CISD1 | |
| SCHEMBL16111387 | 0.90 | MAPT (0.74) | MAPTAPPSLC16A3SLC16A1CISD1 | |
| SCHEMBL14948624 | 0.90 | MAPT (0.74) | MAPTAPPSLC16A3SLC16A1CISD1 | |
| SCHEMBL10059202 | 0.90 | MAPT (0.62) | MAPTSLC16A3SLC16A1CISD1KDM4E | |
| SCHEMBL15431231 | 0.90 | MAPT (0.62) | MAPTSLC16A3SLC16A1CISD1KDM4E | |
| SCHEMBL7006818 | 0.90 | MAPT (0.62) | MAPTSLC16A3SLC16A1CISD1KDM4E | |
| SCHEMBL3364527 | 0.88 | MAPT (0.62) | MAPTAPPSLC16A3SLC16A1CISD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9959982-B2 | Photoelectric conversion element and method for producing the same | Konica Minolta, Inc. (JP) | 2018-05-01 | — | — | US | disclosed |
| US-20160155574-A1 | PHOTOELECTRIC CONVERSION ELEMENT MODULE AND METHOD FOR MANUFACTURING THE SAME | Konica Minolta, Inc. (JP) | 2016-06-02 | — | — | US | disclosed |
| US-20150243445-A1 | PHOTOELECTRIC CONVERSION ELEMENT AND METHOD FOR PRODUCING THE SAME | Konica Minolta, Inc. (JP) | 2015-08-27 | — | — | US | disclosed |
| US-20130061929-A1 | PHOTOELECTRIC CONVERSION ELEMENT, METHOD FOR PRODUCING PHOTOELECTRIC CONVERSION ELEMENT, AND SOLAR CELL | KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) | 2013-03-14 | — | — | US | disclosed |
| EP-1628356-B1 | DYE-SENSITIZED PHOTOELECTRIC CONVERSION DEVICE | NIPPON KAYAKU KK (JP) | 2012-08-15 | — | — | EP | disclosed |
| US-8227690-B2 | Dye-sensitized photoelectric conversion device | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2012-07-24 | — | — | US | disclosed |
| US-8227690-B2 | Dye-sensitized photoelectric conversion device | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2012-07-24 | — | — | US | disclosed |
| US-8183393-B2 | Dye compound and dye-sensitized solar cell | ACADEMIA SINICA (TW) | 2012-05-22 | — | — | US | disclosed |
| US-8183393-B2 | Dye compound and dye-sensitized solar cell | ACADEMIA SINICA (TW) | 2012-05-22 | — | — | US | disclosed |
| US-20100076205-A1 | DYE COMPOUND AND DYE-SENSITIZED SOLAR CELL | ACADEMIA SINICA (TW) | 2010-03-25 | — | — | US | disclosed |
| US-20100076205-A1 | DYE COMPOUND AND DYE-SENSITIZED SOLAR CELL | ACADEMIA SINICA (TW) | 2010-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100076205-A1 | DYE COMPOUND AND DYE-SENSITIZED SOLAR CELL | CRY1, DSG1, CRY2 | MAPT 4399/4885APP 2553/4885SLC16A3 3316/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.